Skip to main content
. 2022 Dec 9;14(12):2761. doi: 10.3390/pharmaceutics14122761

Figure 1.

Figure 1

Effect of intraperitoneal (i.p.) injections with a high dose of auranofin (AF) on 344SQ tumor-bearing 129S2/SvPasCrl (129)-mice. (A) Tumor growth kinetics of 344SQ tumor-bearing 129-mice after treatment with 10 mg/kg AF via i.p. injections for 14 consecutive days. (B) Body weight of 129-mice after daily treatment with 10mg/kg AF via i.p. injections over a period of 14 days. Data represent mean ± SD. N = 5 mice per group. *** p ≤ 0.001.